|RANKL expression is related to the differentiation state of human osteoblasts|
GJ Atkins, P Kostakis, B Pan, A Farrugia, S Gronthos, A Evdokiou, ...
Journal of Bone and Mineral Research 18 (6), 1088-1098, 2003
|Zoledronic acid protects against osteosarcoma‐induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat model|
A Labrinidis, S Hay, V Liapis, DM Findlay, A Evdokiou
International journal of cancer 127 (2), 345-354, 2010
|Sclerostin is a locally acting regulator of late‐osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE‐ASARM‐dependent mechanism|
GJ Atkins, PS Rowe, HP Lim, KJ Welldon, R Ormsby, AR Wijenayaka, ...
Journal of Bone and Mineral Research 26 (7), 1425-1436, 2011
|Expression of osteoclast differentiation signals by stromal elements of giant cell tumors|
GJ Atkins, DR Haynes, SE Graves, A Evdokiou, S Hay, S Bouralexis, ...
Journal of Bone and Mineral Research 15 (4), 640-649, 2000
|Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL‐induced apoptosis|
A Evdokiou, S Bouralexis, GJ Atkins, F Chai, S Hay, M Clayer, DM Findlay
International journal of cancer 99 (4), 491-504, 2002
|Pro‐inflammatory cytokines TNF‐related weak inducer of apoptosis (TWEAK) and TNFα induce the mitogen‐activated protein kinase (MAPK)‐dependent expression of sclerostin in human …|
C Vincent, DM Findlay, KJ Welldon, AR Wijenayaka, TS Zheng, ...
Journal of bone and mineral research 24 (8), 1434-1449, 2009
|Death to the bad guys: targeting cancer via Apo2L/TRAIL|
S Bouralexis, DM Findlay, A Evdokiou
Apoptosis 10 (1), 35-51, 2005
|The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro|
B Pan, LB To, AN Farrugia, DM Findlay, J Green, S Gronthos, A Evdokiou, ...
Bone 34 (1), 112-123, 2004
|RANK expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone|
GJ Atkins, P Kostakis, C Vincent, AN Farrugia, JP Houchins, DM Findlay, ...
Journal of Bone and Mineral Research 21 (9), 1339-1349, 2006
|Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone|
GJ Atkins, S Bouralexis, DR Haynes, SE Graves, SM Geary, A Evdokiou, ...
Bone 28 (4), 370-377, 2001
|Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli|
N Ito, AR Wijenayaka, M Prideaux, M Kogawa, RT Ormsby, A Evdokiou, ...
Molecular and cellular endocrinology 399, 208-218, 2015
|Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis|
A Evdokiou, A Labrinidis, S Bouralexis, S Hay, DM Findlay
Bone 33 (2), 216-228, 2003
|Involvement of p21Waf1/Cip1 and its cleavage by DEVD-caspase during apoptosis of colorectal cancer cells induced by butyrate|
F Chai, A Evdokiou, GP Young, PD Zalewski
Carcinogenesis 21 (1), 7-14, 2000
|Suberoylanilide hydroxamic acid (vorinostat) represses androgen receptor expression and acts synergistically with an androgen receptor antagonist to inhibit prostate cancer …|
DL Marrocco, WD Tilley, T Bianco-Miotto, A Evdokiou, HI Scher, ...
Molecular cancer therapeutics 6 (1), 51-60, 2007
|Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome|
PM Neilsen, JE Noll, RJ Suetani, RB Schulz, F Al-Ejeh, A Evdokiou, ...
Oncotarget 2 (12), 1203, 2011
|Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy|
S Bouralexis, DM Findlay, GJ Atkins, A Labrinidis, S Hay, A Evdokiou
British journal of cancer 89 (1), 206-214, 2003
|Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells|
JE Noll, SA Williams, CM Tong, H Wang, JM Quach, LE Purton, ...
haematologica 99 (1), 163, 2014
|The role of osteoclasts and tumour-associated macrophages in osteosarcoma metastasis|
L Endo-Munoz, A Evdokiou, NA Saunders
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1826 (2), 434-442, 2012
|Nutlin-3a is a potential therapeutic for ewing sarcoma|
KI Pishas, F Al-Ejeh, I Zinonos, R Kumar, A Evdokiou, MP Brown, ...
Clinical Cancer Research 17 (3), 494-504, 2011
|SaOS2 osteosarcoma cells as an in vitro model for studying the transition of human osteoblasts to osteocytes|
M Prideaux, AR Wijenayaka, DD Kumarasinghe, RT Ormsby, A Evdokiou, ...
Calcified tissue international 95 (2), 183-193, 2014